These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of two grading systems for epistaxis in hereditary haemorrhagic telangiectasia. Jorgensen OJ; Steineger J; Bachmann-Harildstad G; Dheyauldeen S Rhinology; 2021 Apr; 59(2):212-218. PubMed ID: 33821857 [TBL] [Abstract][Full Text] [Related]
27. Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model. Peng HL; Yi YF; Zhou SK; Xie SS; Zhang GS Chin Med J (Engl); 2015 Nov; 128(22):3050-4. PubMed ID: 26608985 [TBL] [Abstract][Full Text] [Related]
28. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis. Luk L; Mace JC; Bhandarkar ND; Sautter NB Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397 [TBL] [Abstract][Full Text] [Related]
29. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia. Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701 [TBL] [Abstract][Full Text] [Related]
30. Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds. Marcos S; Botella LM; Albiñana V; Arbia A; de Rosales AM J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501293 [TBL] [Abstract][Full Text] [Related]
31. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064 [TBL] [Abstract][Full Text] [Related]
32. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia. Al-Deen S; Bachmann-Harildstad G Rhinology; 2008 Dec; 46(4):281-4. PubMed ID: 19145996 [TBL] [Abstract][Full Text] [Related]
33. Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management. Sautter NB; Smith TL Int Forum Allergy Rhinol; 2012; 2(5):422-31. PubMed ID: 22566463 [TBL] [Abstract][Full Text] [Related]
34. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study. Dheyauldeen S; Abdelnoor M; Bachmann-Harildstad G Am J Rhinol Allergy; 2011; 25(4):214-8. PubMed ID: 21819756 [TBL] [Abstract][Full Text] [Related]
35. Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test-Retest Reliability. Gong AJ; Bolsegui ML; Lee EE; Mathai SC; Weiss CR Am J Rhinol Allergy; 2024 Jan; 38(1):38-46. PubMed ID: 37822162 [TBL] [Abstract][Full Text] [Related]
37. A new endoscopic staging system for hereditary hemorrhagic telangiectasia. Reh DD; Yin LX; Laaeq K; Merlo CA Int Forum Allergy Rhinol; 2014 Aug; 4(8):635-9. PubMed ID: 24782401 [TBL] [Abstract][Full Text] [Related]
38. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia]. Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid]. Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407 [TBL] [Abstract][Full Text] [Related]
40. Intranasal bevacizumab in the treatment of HHT -related epistaxis: a systematic review. Stokes P; Rimmer J Rhinology; 2018 Mar; 56(1):3-10. PubMed ID: 29166422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]